A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in later stages of the disease.
Category: DNA (Deoxyribonucleic Acid)
-
23andMe Customers Did Not Expect Their DNA Data Would Be Sold, Lawsuit Claims
The genetic-testing company, which collected DNA data from users, is for sale in bankruptcy court. Now, 27 states and the District of Columbia oppose selling the data without express consent.
-
23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million
Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.
-
As 23andMe Struggles, Concerns Surface About Its Genetic Data
A plummet in the company’s valuation and a recent board resignation have raised questions about the future of genetic data collected from millions of customers.
-
How AI and DNA Are Unlocking the Mysteries of Global Supply Chains
Firms are turning to advanced technologies to help answer a surprisingly tricky question: Where do products really come from?
-
DNA From Beethoven’s Hair Unlocks Medical and Family Secrets
By analyzing seven samples of hair said to have come from Ludwig van Beethoven, researchers debunked myths about the revered composer while raising new questions about his life and death.